HLBBF
Price
$5.52
Change
+$0.37 (+7.18%)
Updated
Aug 12 closing price
Capitalization
5.86B
HLNCF
Price
$4.82
Change
+$0.13 (+2.77%)
Updated
Aug 15 closing price
Capitalization
43.62B
Interact to see
Advertisement

HLBBF vs HLNCF

Header iconHLBBF vs HLNCF Comparison
Open Charts HLBBF vs HLNCFBanner chart's image
H. Lundbeck A/S
Price$5.52
Change+$0.37 (+7.18%)
Volume$1.7K
Capitalization5.86B
HALEON
Price$4.82
Change+$0.13 (+2.77%)
Volume$5.58K
Capitalization43.62B
HLBBF vs HLNCF Comparison Chart in %
Loading...
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLBBF vs. HLNCF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLBBF is a StrongBuy and HLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (HLBBF: $5.52 vs. HLNCF: $4.82)
Brand notoriety: HLBBF and HLNCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLBBF: 484% vs. HLNCF: 34%
Market capitalization -- HLBBF: $5.86B vs. HLNCF: $43.62B
HLBBF [@Pharmaceuticals: Generic] is valued at $5.86B. HLNCF’s [@Pharmaceuticals: Generic] market capitalization is $43.62B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLBBF’s FA Score shows that 1 FA rating(s) are green whileHLNCF’s FA Score has 1 green FA rating(s).

  • HLBBF’s FA Score: 1 green, 4 red.
  • HLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, HLBBF is a better buy in the long-term than HLNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLBBF’s TA Score shows that 3 TA indicator(s) are bullish while HLNCF’s TA Score has 4 bullish TA indicator(s).

  • HLBBF’s TA Score: 3 bullish, 5 bearish.
  • HLNCF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HLNCF is a better buy in the short-term than HLBBF.

Price Growth

HLBBF (@Pharmaceuticals: Generic) experienced а +7.09% price change this week, while HLNCF (@Pharmaceuticals: Generic) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($43.6B) has a higher market cap than HLBBF($5.86B). HLNCF has higher P/E ratio than HLBBF: HLNCF (21.25) vs HLBBF (9.98). HLNCF YTD gains are higher at: 2.991 vs. HLBBF (-10.324). HLBBF has higher annual earnings (EBITDA): 4.25B vs. HLNCF (2.71B). HLBBF has more cash in the bank: 2.7B vs. HLNCF (676M). HLNCF has less debt than HLBBF: HLNCF (8.45B) vs HLBBF (15.2B). HLBBF has higher revenues than HLNCF: HLBBF (23B) vs HLNCF (11B).
HLBBFHLNCFHLBBF / HLNCF
Capitalization5.86B43.6B13%
EBITDA4.25B2.71B157%
Gain YTD-10.3242.991-345%
P/E Ratio9.9821.2547%
Revenue23B11B209%
Total Cash2.7B676M399%
Total Debt15.2B8.45B180%
TECHNICAL ANALYSIS
Technical Analysis
HLBBFHLNCF
RSI
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
53%
Momentum
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
36%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMSGX22.67N/A
N/A
VALIC Company I Mid Cap Strategic Gr
UGMVX11.98N/A
N/A
Victory Global Managed Volatility
RYZCX134.46N/A
N/A
Rydex Precious Metals C
TRWFX25.19N/A
N/A
Transamerica International Equity R4
CGFEX81.95-0.06
-0.07%
American Funds Growth Fund of Amer 529E

HLBBF and

Correlation & Price change

A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
HYEX - HLBBF
21%
Poorly correlated
N/A
HLUBF - HLBBF
18%
Poorly correlated
N/A
HLN - HLBBF
10%
Poorly correlated
+0.09%
HLNCF - HLBBF
8%
Poorly correlated
+2.77%
STEK - HLBBF
2%
Poorly correlated
+0.55%
More

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+2.77%
HLN - HLNCF
49%
Loosely correlated
+0.09%
SGIOF - HLNCF
21%
Poorly correlated
+13.16%
STEK - HLNCF
11%
Poorly correlated
+0.55%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.69%
More